These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 28511023

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH.
    Torquato P, Giusepponi D, Alisi A, Galarini R, Bartolini D, Piroddi M, Goracci L, Di Veroli A, Cruciani G, Crudele A, Nobili V, Galli F.
    Sci Rep; 2019 Feb 14; 9(1):2045. PubMed ID: 30765737
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
    Pacifico L, Bonci E, Di Martino M, Versacci P, Andreoli G, Silvestri LM, Chiesa C.
    Nutr Metab Cardiovasc Dis; 2015 Aug 14; 25(8):734-41. PubMed ID: 26026214
    [Abstract] [Full Text] [Related]

  • 5. Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.
    Polyzos SA, Kountouras J, Mantzoros CS, Polymerou V, Katsinelos P.
    Diabetes Obes Metab; 2017 Dec 14; 19(12):1805-1809. PubMed ID: 28452101
    [Abstract] [Full Text] [Related]

  • 6. Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children.
    Nobili V, Alisi A, Della Corte C, Risé P, Galli C, Agostoni C, Bedogni G.
    Nutr Metab Cardiovasc Dis; 2013 Nov 14; 23(11):1066-70. PubMed ID: 23220074
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.
    Li YH, Yang LH, Sha KH, Liu TG, Zhang LG, Liu XX.
    World J Gastroenterol; 2015 Jun 14; 21(22):7008-13. PubMed ID: 26078579
    [Abstract] [Full Text] [Related]

  • 9. Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial.
    Della Corte C, Carpino G, De Vito R, De Stefanis C, Alisi A, Cianfarani S, Overi D, Mosca A, Stronati L, Cucchiara S, Raponi M, Gaudio E, Byrne CD, Nobili V.
    PLoS One; 2016 Jun 14; 11(12):e0168216. PubMed ID: 27977757
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study.
    Kedarisetty CK, Bhardwaj A, Kumar G, Rastogi A, Bihari C, Kumar M, Sarin SK.
    Indian J Gastroenterol; 2021 Feb 14; 40(1):41-49. PubMed ID: 33772456
    [Abstract] [Full Text] [Related]

  • 14. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Sato K, Gosho M, Yamamoto T, Kobayashi Y, Ishii N, Ohashi T, Nakade Y, Ito K, Fukuzawa Y, Yoneda M.
    Nutrition; 2015 Feb 14; 31(7-8):923-30. PubMed ID: 26059365
    [Abstract] [Full Text] [Related]

  • 15. Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis.
    Dasarathy S, Dasarathy J, Khiyami A, Yerian L, Hawkins C, Sargent R, McCullough AJ.
    J Clin Gastroenterol; 2015 Feb 14; 49(2):137-44. PubMed ID: 24583757
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial.
    Bril F, Biernacki DM, Kalavalapalli S, Lomonaco R, Subbarayan SK, Lai J, Tio F, Suman A, Orsak BK, Hecht J, Cusi K.
    Diabetes Care; 2019 Aug 14; 42(8):1481-1488. PubMed ID: 31332029
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.
    Dufour JF, Oneta CM, Gonvers JJ, Bihl F, Cerny A, Cereda JM, Zala JF, Helbling B, Steuerwald M, Zimmermann A, Swiss Association for the Study of the Liver.
    Clin Gastroenterol Hepatol; 2006 Dec 14; 4(12):1537-43. PubMed ID: 17162245
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.